- TSMC (TSM.US) and Sony (SONY.US) finalize $4.7 billion joint venture agreement to mass produce next-generation image sensors in 2029
- TSMC (TSM.US) and Sony (SONY.US) finalize a 4.7 billion dollar joint venture agreement to mass produce next-generation image sensors in 2029.
- Spot platinum has just surpassed the $1,750.00/ounce mark, now quoted at $1,749.78/ounce, down 0.18% on the day; Nymex platinum futures main contract is now quoted at $1,762.6/ounce, up 0.51% on the day.
- According to documents from the U.S. Securities and Exchange Commission, the Swiss National Bank reported holding 1.5 million Class A shares of SpaceX (SPCX.US) as of June 30.
- Will there be a “dovish surprise” in tomorrow’s US CPI? Goldman Sachs says inflation may be lower than widespread expectations, while HSBC bets on “moderate” data.
- Spot platinum has just surpassed the $1,760.00/oz mark, last trading at $1,758.47/oz, up 0.32% on the day; Nymex platinum futures for the main contract are now at $1,770.1/oz, up 0.94% on the day.
- Marketing Alliance 1Q EPS 14c >MAAL
- Xylem To Acquire Cornell Pump And Roper Pump, Strengthening Industrial Presence In High Growth Sectors >XYL
- Tether loses $4 billion market cap in 60 days, CryptoQuant signals bear market end
- Curaleaf: Proposed Offer Reflects a 45% Premium to Aurora's 30-Day VWAP and a 110% Premium to Aurora's 30-Day VWAP Excluding Balance Sheet Cash
- Curaleaf Announces Intention to Launch Takeover Bid for Aurora Cannabis
- The largest IPO in AI history is approaching! Anthropic's valuation nears 1 trillion dollars, with revenue growth surpassing OpenAI
- Breakthrough in the Hormuz Standoff, US Stock Futures Await Inflation Verdict
- Dogecoin ETFs record zero net inflows as traders eye key inflation data
- IBM: Under a multi-year $240 million agreement, the company plans to deploy a large number of Nvidia HGX B300 systems on IBM Cloud, which are expected to be available in the first quarter of 2027.
- Nearly $100 billion of intervention can't stop the yen from heading straight to 160? Yen exchange rate gives back nearly half of its rebound, US-Japan joint intervention effect is fading
- CME announces round-the-clock trading for silver futures, with weekend trading for gold already proving effective
- CME Group will expand the round-the-clock trading range to 100-ounce silver futures.
- CME Group: Since its launch on July 24, the trading volume for 1-ounce gold futures during weekends has exceeded $200 million.
- Barrick names Bock to lead overseas arm ahead of split
- Wells Fargo urges hedging ahead of July CPI as sell trigger peaks
- IBM (IBM.US): Signs a multi-year $240 million agreement with Together AI to deploy NVIDIA HGX B300 clusters on IBM Cloud.
- CME Group: 24-hour around-the-clock trading for silver will launch on September 11.
- CME Group will expand round-the-clock trading to include 100-ounce silver futures.
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Big Sky Industrial 2Q Production Was 33,747 Barrels of Oil Equivalent >BSIN
- US Stock Market Preview | All Three Major Index Futures Rise, Nvidia (NVDA.US) Teams Up with Wall Street to Leverage $500 Billion, Yen Approaches 160 Again
- Egypt's Ministry of Energy: Egypt will launch the Meleiha gas plant next month.
- CME Group to Launch 24-Hour Silver Trading on September 11
- Theriva Biologics 2Q Loss $3.22M >TOVX
- Kalaris Therapeutics 2Q Loss $11.5M >KLRS
- Kalaris Therapeutics 2Q Loss/Shr 48c >KLRS
- Dominari Holdings 2Q Loss/Shr 24c >DOMH
- TRX staking declines as TRON’s Q2 USDT transfers hit $2.1T: Can demand beat supply?
- Joby Aviation to Acquire Resonant Sciences for About $500M >JOBY
- Coya Therapeutics 2Q Research and Development Expenses $5.0M >COYA
- Reuters survey: The yield on the US two-year Treasury note is expected to drop to 4.07% within three months, 3.92% within six months, and 3.80% within one year (the July survey indicated 4.00%, 3.90%, and 3.85% respectively).
- Reuters survey: 18 out of 22 bond strategists say that over the next three months, the yield on the US 10-year Treasury bond is more likely to exceed expectations than fall below them.
- Reuters survey: The yield on 10-year US Treasury bonds is expected to fall to 4.50% in three months and remain at that level for the following three months, dropping to 4.34% after one year (July survey figures were 4.48%, 4.48%, and 4.39%, respectively).
- Coya Therapeutics 2Q Rev $243,745 >COYA
- LB Pharmaceuticals 2Q Research and Development Expenses $44.1M >LBRX
- Analyst Who Called $3.37 XRP Top States What to Expect If XRP Breaks $1.01
- Rhythm Pharmaceuticals Announces IMCIVREE(R) (setmelanotide) Receives Expanded Marketing Authorization In The United Kingdom For Treatment Of Obesity And Control Of Hunger In Patients With Acquired Hypothalamic Obesity Due To Hypothalamic Injury Or Impairment >RYTM
- Big Sky Industrial 2Q Loss $2.34M >BSIN
- Big Sky Industrial 2Q Loss/Shr 4c >BSIN
- LB Pharmaceuticals 2Q Loss/Shr $1.71 >LBRX
- Fort Technology Signs Agreements For The Acquisition Of Logia USA - Fuel Integrity Solutions For Data Centers Company >FORT.V
- Big Sky Industrial 2Q Rev $2.13M >BSIN
- Bitcoin decouples from software stocks, signaling investor shifts
- Foreign Media: After XRP Accounts Surpass 8 Million, the Top 1% Threshold Drops to 44,771 Tokens
- web3: XLM falls below key support, derivatives data weakens
- US Dollar: CPI keeps USD in tight ranges – OCBC
- Token Unlocks This Week: Why Supply Share Matters More Than Value
- Web3: Bitcoin falls below $64,000, ETFs turn to net outflows
- GBP/USD Price Forecast: Holds Descending Triangle breakout
- Qatar says Oman-Iran talks reach advanced stage
- A storage tank at Libya's main oil refinery was hit and caught fire.
- Neuronetics 2Q Loss $3.44M >STIM
- US Stock Movement | Beyond Meat Plunges 21% in Pre-market Trading
- $19 Billion AI Bet Backfires as Korean Retail Suffers Worst KOSPI Crash Since 2008
- Market News: The total assets under management in the German fund industry have surpassed €5 trillion for the first time.
- Nvidia’s $500B AI Infrastructure Push Could Deepen Divide With Decentralized Networks
- Breaking: National Bank of Canada Reveals Holdings In XRP ETF, Bitcoin ETFs
- Natural gas: European prices surge as LNG flows stall – ING
- Farewell to "K-shaped divergence"? PNC report: The gap in consumption between high- and low-income households in the U.S. will basically disappear by 2026, with the labor market as the key support
- The SEC will discuss a regulatory framework for crypto token issuance.
- From 1.5GW Reservation to $20 Billion Valuation Ambition: Singapore Data Center Operator DayOne Rushes for US IPO
- From 1.5GW Bookings to a $20 Billion Ambition: Singapore Data Center Operator DayOne Races Toward US IPO
- Egypt: MELEIHA Natural Gas Plant Project in the Western Desert to Begin Operations Next Month with a Daily Capacity of 100 Million Cubic Feet
- Intensity Therapeutics 2Q Loss/Shr $1.11 >INTS
- Intensity Therapeutics 2Q Loss $3.01M >INTS
- Neurogene 2Q Loss/Shr $1.53 >NGNE
- Neurogene 2Q Research & Development Expenses $25.5M >NGNE
- Bicara Names Jenn Larson CFO
- Trump Media & Technology Group stock wobbles after $238M quarterly loss
- Chainlink crypto nears 9.48 resistance as RSI hits overbought 77.61
- Bitget Protection Fund valuation climbs to $351M as Bitcoin rallies in July
- Ambiq Micro 2Q Loss/Shr 32c >AMBQ
- Sagimet Biosciences 2Q Loss/Shr 26c >SGMT
- Zura Bio Expects Existing Cash and Cash Equivalents Sufficient to Support Planned Ops Through at Least End of 2028 >ZURA
- Ambiq Micro 2Q Sales $33.9M >AMBQ
- Bicara Therapeutics 2Q Loss/Shr 82c >BCAX
- Zura Bio 2Q Loss $26.3M >ZURA
- Stellar price risks a deeper correction toward $0.142
- Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
- Xtant Medical Holdings Cuts 2026 View To Rev $99M-$103M >XTNT
- Hemab Therapeutics 2Q Research and Development Expenses $20.3M >COAG
- Fennec Pharmaceuticals 2Q Rev $17.9M >FRX.T
- Fennec Pharmaceuticals 2Q EPS 5c >FRX.T
- CalciMedica 2Q Research and Development Expenses $2.1M >CALC
- Terrestrial Energy 2Q Loss/Shr 9c >IMSR
- CalciMedica 2Q Loss/Shr 45c >CALC
- 908 Devices Narrows 2026 View To Rev $68.0M-$70.0M >MASS
- Aura Biosciences 2Q Loss/Shr 48c >AURA
- 908 Devices 2Q Loss/Shr 32c >MASS
- CVRx: Paul Verrastro to Assume Role of Interim Head of Sales, Effective Immediately >CVRX
- Xtant Medical Holdings 2Q Rev $23M >XTNT